Rapid detection of health-care-associated bloodstream infection in critical care using Multipathogen real-time polymerase chain reaction technology: A diagnostic accuracy study and systematic review

Health Technology Assessment

Volumn 19, Issue 35, 2015, Pages 1-141

  Warhurst, Geoffrey ^a,b   Dunn, Graham ^a   Chadwick, Paul ^a   Blackwood, Bronagh ^c   McAuley, Daniel ^c   Perkins, Gavin D ^d   McMullan, Ronan ^e   Gates, Simon ^d   Bentley, Andrew ^a,f   Young, Duncan ^g   Carlson, Gordon L ^a   Dark, Paul ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF SALFORD   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e ROYAL VICTORIA HOSPITAL   (United Kingdom)

^f MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ACINETOBACTER BAUMANNII; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIUM DETECTION; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FUNGAL DETECTION; HEALTHCARE ASSOCIATED INFECTION; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; PICHIA KUDRIAVZEVII; POLYMERASE CHAIN REACTION SYSTEM; PREDICTIVE VALUE; PREVALENCE; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RAPID TEST; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIFAST; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; BACTEREMIA; BIOMEDICAL TECHNOLOGY ASSESSMENT; CROSS INFECTION; ECONOMICS; LABORATORY DIAGNOSIS; NATIONAL HEALTH SERVICE; PROSPECTIVE STUDY; STANDARDS; TIME; UNITED KINGDOM;

BACTEREMIA; CRITICAL CARE; CROSS INFECTION; ENGLAND; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STATE MEDICINE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TIME FACTORS;

EID: 84929256831     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta19350     Document Type: Article

References (107)

1. Comptroller and Auditor General. Reducing Healthcare Associated Infection in Hospitals in England. London: National Audit Office HC 560; 2009.
2. Davies PD. Infections and the Rise of Antimicrobial Resistance. London: Department of Health; 2013.
3. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013;173:2039–46. http://dx.doi.org/10.1001/jamainternmed.2013.9763
4. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–601. http://dx.doi.org/10.1001/jama.1994.03510440058033
5. Health Protection Agency. Healthcare-Associated Infections and Antimicrobial Resistance: 2009/10. URL: www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1281954479045 (accessed November 2013).
6. Edgeworth JD, Treacher DF, Eykyn SJ. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999;27:1421–8. http://dx.doi.org/10.1097/00003246-199908000-00002
7. Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005;33:1538–48. http://dx.doi.org/10.1097/01.CCM.0000168253.91200.83
8. Health Protection Agency. Investigation of BCs (for Organisms Other Than Mycobacterium Species). National Standard Method. London: Standards Unit; 2005.
9. Weinstein MP. BC contamination: persisting problems and partial progress. J Clin Microbiol 2003;41:2275–8. http://dx.doi.org/10.1128/JCM.41.6.2275-2278.2003
10. Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885–91. http://dx.doi.org/10.1038/nature01326
11. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2012;41:580–637. http://dx.doi.org/10.1097/CCM.0b013e31827e83af
12. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992;101:1481–3. http://dx.doi.org/10.1378/chest.101.6.1481
13. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462–74. http://dx.doi.org/10.1378/chest.115.2.462
14. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589–96. http://dx.doi.org/10.1097/01.CCM.0000217961.75225.E9
15. Cavaillon J-M, Adrie C. Sepsis and Non-Infectious Systemic Inflammation: From Biology to Critical Care. Weinheim: Wiley-VCH; 2009.
16. Sprung CL, Sakr Y, Vincent JL, Le Gall JR, Reinhart K, Ranieri VM, et al. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely ill Patients (SOAP) study. Intensive Care Med 2006;32:421–7. http://dx.doi.org/10.1007/s00134-005-0039-8
17. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000;26:S64–74. http://dx.doi.org/10.1007/s001340051121
18. Moudgal V, Sobel JD. Clostridium difficile colitis: a review. Hosp Pract 2012;40:139–48. http://dx.doi.org/10.3810/hp.2012.02.954
19. World Health Organization. The Evolving Threat of Antimicrobial Resistance: Options for Action. Geneva: World Health Organization; 2012.
20. Peters RP, van Agtmael MA, Danner SA, Savelkoul PH, Vandenbroucke-Grauls CM. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004;4:751–60. http://dx.doi.org/10.1016/S1473-3099(04)01205-8
21. Dark PM, Dean P, Warhurst G. Bench-to-bedside review: the promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection. Crit Care 2009;13:217–22. http://dx.doi.org/10.1186/cc7886
22. Bauer M, Reinhart K. Molecular diagnostics of sepsis – where are we today? Int J Med Microbiol 2010;300:411–13. http://dx.doi.org/10.1016/j.ijmm.2010.04.006
23. Arpi M, Bentzon MW, Jensen J, Frederiksen W. Importance of blood volume cultured in the detection of bacteremia. Eur J Clin Microbiol Infect Dis 1989;8:838–42. http://dx.doi.org/10.1007/BF02185857
24. Mermel LA, Maki DG. Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 1993;119:270–2. http://dx.doi.org/10.7326/0003-4819-119-4-199308150-00003
25. Bretagne S, Costa JM. Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol 2005;45:361–8. http://dx.doi.org/10.1016/j.femsim.2005.05.012
26. Wellinghausen N, Kochem AJ, Disqué C, Mühl H, Gebert S, Winter J, et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol 2009;47:2759–65. http://dx.doi.org/10.1128/JCM.00567-09
27. Wolk DM, Kaleta EJ, Wysocki VH. PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories. J Mol Diagn 2012;14:295–304. http://dx.doi.org/10.1016/j.jmoldx.2012.02.005
28. Ozbak H, Dark P, Maddi S, Chadwick P, Warhurst G. Combined molecular gram typing and high-resolution melting analysis for rapid identification of a syndromic panel of bacteria responsible for sepsis-associated bloodstream infection. J Mol Diagn 2012;14:176–84. http://dx.doi.org/10.1016/j.jmoldx.2011.12.004
29. Lehmann LE, Hunfeld KP, Emrich T, Haberhausen G, Wissing H, Hoeft A, et al. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 2008;197:313–24. http://dx.doi.org/10.1007/s00430-007-0063-0
30. Zucol F, Ammann RA, Berger C, Aebi C, Altwegg M, Niggli FK, et al. Real-time quantitative broad-range PCR assay for detection of the 16S rRNA gene followed by sequencing for species identification. J Clin Microbiol 2006;44:2750–9. http://dx.doi.org/10.1128/JCM.00112-06
31. Anthony RM, Brown TJ, French GL. Rapid diagnosis of bacteraemia by universal amplification of 23S ribosomal DNA followed by hybridisation to an oligonucleotide array. J Clin Microbiol 2000;38:781–8.
32. Rantakokko-Jalava K, Nikkari S, Jalava J, Eerola E, Skurnik M, Meurman O, et al. Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol 2000;38:32–9.
33. Hsu MC, Chen KW, Lo HJ, Chen YC, Liao MH, Lin YH, et al. Species identification of medically important fungi by use of real-time LightCycler PCR. J Med Microbiol 2003;52:1071–6. http://dx.doi.org/10.1099/jmm.0.05302-0
34. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006;19:165–256. http://dx.doi.org/10.1128/CMR.19.1.165-256.2006
35. Menezes LC, Rocchetti TT, Bauab Kde C, Cappellano P, Quiles MG, Carlesse F, et al. Diagnosis by real-time polymerase chain reaction of pathogens and antimicrobial resistance genes in bone marrow transplant patients with bloodstream infections. BMC Infect Dis 2013;13:166–72. http://dx.doi.org/10.1186/1471-2334-13-166
36. Pletz MW, Wellinghausen N, Welte T. Will polymerase chain reaction (PCR) based diagnostics improve outcome in septic patients? A clinical view. Intensive Care Med 2011;37:1069–76. http://dx.doi.org/10.1007/s00134-011-2245-x
37. Leitner E, Kessler HH, Spindelboeck W, Hoenigl M, Putz-Bankuti C, Stadlbauer-Köllner V, et al. Comparison of two molecular assays with conventional BC for diagnosis of sepsis. J Microbiol Methods 2013;92:253–5. http://dx.doi.org/10.1016/j.mimet.2012.12.012
38. Bloos F, Sachse S, Kortgen A, Pletz MW, Lehmann M, Straube E, et al. Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study. PLOS ONE 2012;7:e46003. http://dx.doi.org/10.1371/journal.pone.0046003
39. Fitting C, Parlato M, Adib-Conquy M, Memain N, Philippart F, Misset B, et al. DNAemia detection by multiplex PCR and biomarkers for infection in systemic inflammatory response syndrome patients. PLOS ONE 2012;7:e38916. http://dx.doi.org/10.1371/journal.pone.0038916
40. Jordana-Lluch E, Carolan HE, Giménez M, Sampath R, Ecker DJ, Quesada MD, et al. Rapid diagnosis of bloodstream infections with PCR followed by mass spectrometry. PLOS ONE 2013;8:e62108. http://dx.doi.org/10.1371/journal.pone.0062108
41. Louie RF, Tang Z, Albertson TE, Cohen S, Tran NK, Kost GJ. Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 2008;36:1487–92. http://dx.doi.org/10.1097/CCM.0b013e31816f487c
42. Mancini N, Clerici D, Diotti R, Perotti M, Ghidoli N, De Marco D, et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol 2008;57:601–4. http://dx.doi.org/10.1099/jmm.0.47732-0
43. Molina JM, Córdoba J, Ramírez P, Gobernado M. Automatic detection of bacterial and fungal infections in the blood. Enferm Infec Microbiol Clin 2008;26(Suppl. 9):75–80.
44. http://dx.doi.org/10.1016/S0213-005X(08)76544-3
45. Dark P, Dunn G, Chadwick P, Young D, Bentley A, Carlson G, et al. The clinical diagnostic accuracy of rapid detection of healthcare-associated bloodstream infection in intensive care using multi-pathogen real-time polymerase chain reaction (real-time PCR) technology. BMJ Open 2011;1:e000181. http://dx.doi.org/10.1136/bmjopen-2011-000181
46. Dark P, Wilson C, Blackwood B, McAuley DF, Perkins GD, McMullan R, et al. Accuracy of LightCycler(R) SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review protocol. BMJ Open 2012;2:e000392. http://dx.doi.org/10.1136/bmjopen-2011-000392
47. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530–8. http://dx.doi.org/10.1007/s00134-003-1662-x
48. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25. http://dx.doi.org/10.1186/1471-2288-3-25
49. Phillips B, Ball C, Sackett D, Badenoch D, Straus D, Haynes B, et al. Oxford Centre for Evidence-Based Medicine – Levels of Evidence (March 2009). 2001. URL: www.cebm.net/oxford-centreevidence-based-medicine-levels-evidence-march-2009/ (accessed 6 January 2012).
50. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005;58:982–90. http://dx.doi.org/10.1016/j.jclinepi.2005.02.022
51. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007;8:239–51. http://dx.doi.org/10.1093/biostatistics/kxl004
52. Diagnostic Test Accuracy Working Group. Handbook for DTA Reviewers. 2013. URL: http://srdta.cochrane.org/handbook-dta-reviews (accessed November 2013).
53. Raglio A, Rizzi M, Amer M, Mangia M, Lucà M, Goglio A. Sepsis Diagnosis by Realtime PCR (SeptiFast Kit, Roche Diagnostics). Proceedings of the 16th European Congress of Clinical Microbiology and Infectious Diseases, Nice, France, 1–4 April 2006. Oxford: Blackwell Publishing; 2006.
54. Klemm M, Prinz M, Nowak A, Morgenstern T, Meisner M, Rothe KF, et al. Clinical application of SeptiFast, a PCR method for the detection of bacteraemia, in intensive care patients. Infection 2007;35(Suppl. 2):12.
55. Bingold TM, Hunfeld K, Scheller B, Rönneberg T. Clinical utility of a new PCR-based assay for rapid pathogen detection (SeptiFast®) in patients with clinical sepsis compared to standard BC. Infection 2007;35(Suppl. 2):15.
56. Vince A, Lepej SZ, Barsić B, Dusek D, Mitrović Z, Serventi-Seiwerth R, et al. LightCycler SeptiFast assay as a tool for the rapid diagnosis of sepsis in patients during antimicrobial therapy. J Med Microbiol 2008;57:1306–7. http://dx.doi.org/10.1099/jmm.0.47797-0
57. Lodes U, Bohmeier B, Meyer F, Koenig B, Lippert H. Microbiologic diagnostic with the novel LightCycler SeptiFast® test during the early phase of surgical sepsis mainlycaused by peritonitis is quicker and more sensitive than conventional microbiological culture. Gastroenterology 2008;134:A621. http://dx.doi.org/10.1016/S0016-5085(08)62901-7
58. Westh H, Lisby G, Breysse F, Böddinghaus B, Chomarat M, Gant V, et al. Multiplex real-time PCR and BC for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect 2009;15:544–51. http://dx.doi.org/10.1111/j.1469-0691.2009.02736.x
59. Varani S, Stanzani M, Paolucci M, Melchionda F, Castellani G, Nardi L, et al. Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. J Infect 2009;58:346–51. http://dx.doi.org/10.1016/j.jinf.2009.03.001
60. Palomares JC, Puche B, Martos A, Lucena F, Marín M, Martín-Mazuelos E. Rapid Molecular Diagnosis of Severe Sepsis in Patients with Symptoms of Severe Sepsis. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsiniki, Finland, 18–19 May 2009. Oxford: Blackwell Publishing; 2009.
61. Lodes U, Meyer F, König B, Lippert H. Microbiological sepsis screening in surgical ICU patients with the ‘LightCycler’ SeptiFast test – a pilot study. Zentralbl Chir 2009;134:249–53. http://dx.doi.org/10.1055/s-0028-1098776
62. Dierkes C, Ehrenstein B, Siebig S, Linde HJ, Reischl U, Salzberger B. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009;9:126. http://dx.doi.org/10.1186/1471-2334-9-126
63. Dark P, Chadwick P, Warhurst G. Detecting sepsis-associated bloodstream infection acquired in intensive care using multi-pathogen real-time PCR. J Infect 2009;59:296–8. http://dx.doi.org/10.1016/j.jinf.2009.08.002
64. Yanagihara K, Kitagawa Y, Tomonaga M, Tsukasaki K, Kohno S, Seki M, et al. Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit. Crit Care 2010;14:R159. http://dx.doi.org/10.1186/cc9234
65. Wallet F, Nseir S, Baumann L, Herwegh S, Sendid B, Boulo M, et al. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect 2010;16:774–9. http://dx.doi.org/10.1111/j.1469-0691.2009.02940.x
66. Tsalik EL, Jones D, Nicholson B, Waring L, Liesenfeld O, Park LP, et al. Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol 2010;48:26–33. http://dx.doi.org/10.1128/JCM.01447-09
67. Sóki J, Szabó E, Hajdú E, Lázár A, Nagy E. Use of a Commercially Available Multiplex Real-Time PCR Assay (SeptiFast) to Detect Bacterial and Fungal Pathogens in Septic Patients. 20th European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, 10–13 April 2010. Oxford: Blackwell Publishing; 2010.
68. Regueiro BJ, Varela-Ledo E, Martinez-Lamas L, Rodriguez-Calviño J, Aguilera A, Santos A, et al. Automated extraction improves multiplex molecular detection of infection in septic patients. PLOS ONE 2010;5:e13387. http://dx.doi.org/10.1371/journal.pone.0013387
69. Maubon D, Hamidfar-Roy R, Courby S, Vesin A, Maurin M, Pavese P, et al. Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J Infect 2010;61:335–42. http://dx.doi.org/10.1016/j.jinf.2010.07.004
70. Lehmann LE, Hunfeld KP, Steinbrucker M, Brade V, Book M, Seifert H, et al. Improved detection of blood stream pathogens by real-time PCR in severe sepsis. Intensive Care Med 2010;36:49–56. http://dx.doi.org/10.1007/s00134-009-1608-z
71. Bloos F, Hinder F, Becker K, Sachse S, Mekontso Dessap A, Straube E, et al. A multicenter trial to compare BC with polymerase chain reaction in severe human sepsis. Intensive Care Med 2010;36:241–7. http://dx.doi.org/10.1007/s00134-009-1705-z
72. Berger A, Altiok I, Mechtler T, Langgartner M, Böhm J, Herkner K, et al. Adaption of the Roche SeptiFast system for the early detection of neonatal sepsis in very low birthweight infants. Klinische Pädiatrie 2010;222(Suppl. 1):S4. http://dx.doi.org/10.1055/s-0030-1261288
73. Avolio M, Diamante P, Zamparo S, Modolo ML, Grosso S, Zigante P, et al. Molecular identification of bloodstream pathogens in patients presenting to the emergency department with suspected sepsis. Shock 2010;34:27–30. http://dx.doi.org/10.1097/SHK.0b013e3181d49299
74. Vrioni G, Daniil I, Mamali V, Kimouli M, Mylona-Petropoulou D, Themeli-Digalaki K, et al. Preliminary Clinical Study using a Multiplex Blood PCR for Rapid Detection of Bacterial and Fungal Pathogens in ICU Patients with Presumed Sepsis. Proceedings of the 21st European Congress of Clinical Microbiology and Infectious Diseases, Milan, Italy, 7–10 May 2011. Oxford: Blackwell Publishing; 2011.
75. Sitnik R, Marra AR, Petroni RC, Ramos OP, Martino MD, Pasternak J, et al. SeptiFast for diagnosis of sepsis in severely ill patients from a Brazilian hospital. J Med Diagn 2011;13:736.
76. Obara H, Aikawa N, Hasegawa N, Hori S, Ikeda Y, Kobayashi Y, et al. The role of a real-time PCR technology for rapid detection and identification of bacterial and fungal pathogens in whole-blood samples. J Infect Chemother 2011;17:327–33. http://dx.doi.org/10.1007/s10156-010-0168-z
77. Lucignano B, Ranno S, Liesenfeld O, Pizzorno B, Putignani L, Bernaschi P, et al. Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis. J Clin Microbiol 2011;49:2252–8. http://dx.doi.org/10.1128/JCM.02460-10
78. Josefson P, Strålin K, Ohlin A, Ennefors T, Dragsten B, Andersson L, et al. Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infections. Eur J Clin Microbiol Infect Dis 2011;30:1127–34. http://dx.doi.org/10.1007/s10096-011-1201-6
79. Hettwer S, Wilhelm J, Schürmann M, Ebelt H, Hammer D, Amoury M, et al. Microbial diagnostics in patients with presumed severe infection in the emergency department. Med Klin Intensivmed Notfmed 2011;107:53–62. http://dx.doi.org/10.1007/s00390-011-0287-5
80. Bravo D, Blanquer J, Tormo M, Aguilar G, Borrás R, Solano C, et al. Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients. Int J Infect Dis 2011;15:e326–31. http://dx.doi.org/10.1016/j.ijid.2011.01.003
81. Tschiedel E, Steinmann J, Buer J, Onnebrink JG, Felderhoff-Müser U, Rath PM, et al. Results and relevance of molecular detection of pathogens by SeptiFast – a retrospective analysis in 75 critically ill children. Klin Padiatr 2012;224:12–16. http://dx.doi.org/10.1055/s-0031-1285878
82. Rath PM, Saner F, Paul A, Lehmann N, Steinmann E, Buer J, et al. Multiplex PCR for rapid and improved diagnosis of bloodstream infections in liver transplant recipients. J Clin Microbiol 2012;50:2069–71. http://dx.doi.org/10.1128/JCM.00745-12
83. Pasqualini L, Mencacci A, Leli C, Montagna P, Cardaccia A, Cenci E, et al. Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol 2012;50:1285–8. http://dx.doi.org/10.1128/JCM.06793-11
84. Mauro MV, Cavalcanti P, Perugini D, Noto A, Sperlì D, Giraldi C. Diagnostic utility of LightCycler SeptiFast and procalcitonin assays in the diagnosis of bloodstream infection in immunocompromised patients. Diagn Microbiol Infect Dis 2012;73:308–11. http://dx.doi.org/10.1016/j.diagmicrobio.2012.04.006
85. Lodes U, Bohmeier B, Lippert H, König B, Meyer F. PCR-based rapid sepsis diagnosis effectively guides clinical treatment in patients with new onset of SIRS. Langenbecks Arch Surg 2012;397:447–55. http://dx.doi.org/10.1007/s00423-011-0870-z
86. Guido M, Quattrocchi M, Zizza A, Pasanisi G, Pavone V, Lobreglio G, et al. Molecular approaches in the diagnosis of sepsis in neutropenic patients with haematological malignances. J Prev Med Hyg 2012;53:104–8.
87. Grif K, Fille M, Würzner R, Weiss G, Lorenz I, Gruber G, et al. Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsis. Wien Klin Wochenschr 2012;124:266–70. http://dx.doi.org/10.1007/s00508-012-0159-4
88. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41–4. http://dx.doi.org/10.1136/bmj.326.7379.41
89. Chang SS, Hsieh WH, Liu TS, Lee SH, Wang CH, Chou HC, et al. Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis – a systemic review and meta-analysis. PLOS ONE 2013;8:e62323. http://dx.doi.org/10.1371/journal.pone.0062323
90. Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 1996;3:895–900. http://dx.doi.org/10.1111/j.1553-2712.1996.tb03538.x
91. HospitalInfection Society. The Third Prevalence Survey of Healthcare Associated Infections in Acute Hospitals in England 2006: Report for Department of Health (England). London: Department of Health; 2007.
92. Dunn G. Regression models for method comparison data. J Biopharm Stat 2007;17:739–56. http://dx.doi.org/10.1080/10543400701329513
93. Human Tissue Authority. Find Out What the HTA Can Do For You. URL: www.hta.gov.uk/ (accessed 16 March 2015).
94. Hospital Episode Statistics. Adult Critical Care in HES: England, 2010–11. 2012. URL: www.hesonline.nhs.uk (accessed November 2013).
95. Felton TW, Sander R, Al-Aloul M, Dark P, Bentley AM. Can a score derived from the Critical Care Minimum Data Set be used as a marker of organ dysfunction? – a pilot study. BMC Res Notes 2009;2:77. http://dx.doi.org/10.1186/1756-0500-2-77
96. Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care 2006;10:R42. http://dx.doi.org/10.1186/cc4854
97. Health Protection Agency UK. Standards for Microbiology Investigations. Investigation of BCs (for Organisms other than Mycobacterium Species), B37. 2013. URL: www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317132857861 (accessed November 2013).
98. Mermel LA, Maki DG. Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 1993;119:270–2. http://dx.doi.org/10.7326/0003-4819-119-4-199308150-00003
99. Bender IB, Seltzer S, Meloff G, Pressman RS. Conditions affecting sensitivity of techniques for detection of bacteremia. J Dent Res 1961;40:951–9. http://dx.doi.org/10.1177/00220345610400052101
100. Dunn G. Methods for Categorical (Binary) Data. In Dunn G. Statistical Evaluation of Measurement Errors. 2nd edn. Hoboken, NJ: John Wiley & Sons; 2009. pp. 144–77.
101. Hui SL, Walter SD. Estimating the error rates of diagnostic tests. Biometrics 1980;36:167–71. http://dx.doi.org/10.2307/2530508
102. Hui SL, Zhou XH. Evaluation of diagnostic tests without gold standards. Stat Methods Med Res 1998;7:354–70. http://dx.doi.org/10.1191/096228098671192352
103. Walter SD, Irwig LM. Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. J Clin Epidemiol 1988;41:923–37. http://dx.doi.org/10.1016/0895-4356(88)90110-2
104. Walter SD, Irwig LM, Glasziou PP. Meta-analysis of diagnostic tests with imperfect reference standards. J Clin Epidemiol 1999;52:943–51. http://dx.doi.org/10.1016/S0895-4356(99)00086-4
105. Waikar SS, Betensky RA, Emerson SC, Bonventre JV. Imperfect gold standards for biomarker evaluation. Clin Trials 2013;10:696–700. http://dx.doi.org/10.1177/1740774513497540
106. Muthén LK, Muthén BO. Mplus User’s Guide. 6th edn. Los Angeles, CA: Muthén & Muthén; 1998–2012. URL: www.statmodel.com/download/usersguide/Mplus%20user%20guide%20Ver_7_r6_web.pdf (accessed November 2013).
107. Great Britain. Data Protection Act 1998. London: The Stationery Office; 1998. URL: www.legislation.gov.uk/ukpga/1998/29/contents/enacted (accessed November 2013).